⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
globenewswire.com
NVS
52nd Annual Nikon Small World Competition Winner Turns an Inkjet Printer into an Unseen Landscape
prnewswire.com
NVS
Essential Thrombocythemia Market in the 7MM Valued at USD 430 Million in 2025, Set to Grow at 12% CAGR Through 2036
globenewswire.com
MRK
NVS
INCY
Just One in Ten Rheumatologists Satisfied with Current Systemic Sclerosis Treatments as Emerging Therapies Raise Expectations, According to Spherix Global Insights
globenewswire.com
BMY
NVS
Global Viral Vector and Plasmid DNA Manufacturing Market, 7th Edition: Forecast to 2035 | 9.73% CAGR Unlocks USD 2.16 Billion CMO and Gene Therapy Opportunity
globenewswire.com
CRL
CAT
TMO
NVS
BNTX
SNY
United States Smart Pills Market - Size, Share, Trends, and Forecast 2026-2034 | AI-Enabled Diagnostics and Drug Delivery Fuel 11.66% CAGR to $4.61 Billion
globenewswire.com
GE
NVS
CCAP
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
globenewswire.com
NVS
Prostate Cancer Foundation Expands Radiopharmaceutical Think Tank as Field Enters Pivotal Growth Phase
businesswire.com
AZN
CLAR
NVS
TLX
ADHD Drugs Market to Reach USD 22.79 Billion by 2035 - Credence Research
prnewswire.com
JNJ
NVS
SUPN
TKO
COLL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS